Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Replimune (REPL) EPS (Weighted Average and Diluted) (2020 - 2025)

Replimune has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.77 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.77 for Q4 2025, up 2.53% from a year ago — trailing twelve months through Dec 2025 was -$3.44 (down 12.05% YoY), and the annual figure for FY2025 was -$3.07, up 5.25%.
  • EPS (Weighted Average and Diluted) reached -$0.77 in Q4 2025 per REPL's latest filing, up from -$0.9 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.41 in Q1 2021 and bottomed at -$0.95 in Q2 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.77 (2023), compared with a mean of -$0.73.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 47.17% in 2022 before it increased 24.44% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.57 in 2021, then decreased by 21.05% to -$0.69 in 2022, then dropped by 11.59% to -$0.77 in 2023, then dropped by 2.6% to -$0.79 in 2024, then rose by 2.53% to -$0.77 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for REPL at -$0.77 in Q4 2025, -$0.9 in Q3 2025, and -$0.95 in Q2 2025.